Reality Check on Human Growth Hormones
Market access for human growth hormones reveals differences in payer coverage across each major channel, as well as specific trends in the drug landscape.
To help make sense of this new research, MMIT's team of experts has analyzed the data for you and summarized the key findings:
- Payer Insights: Increasing restrictions on health exchange and medicare lives
- Class Trends: How long-acting treatments, like biobetters, are shifting prescribing habits
- Key Findings: How quickly prior authorization and step edit policies are evolving
What can pharma do to curb this trend and overcome these challenges?
Get the data behind this change and how it could impact your market access plans from MMIT's team. Their clinical and policy backgrounds provide a unique and expert perspective to help expand your knowledge in the class and guide your decision-making process.
Download the full Reality Check now.